Skip to content
Search
Search
Close this search box.
CUSTOMER SUPPORT
Products
Imbio Technology
XV LVAS®
CT LVAS™
XV Scanner™
Permetium™
Clinical Research
Clinical Studies
Publications
About
About Us
Our Team
Careers
Veteran Advocacy
Investor Relations
Company Information
Corporate Governance
Results + Reports
Share Price and Tools
Investor Services
Investor Contacts
News
Latest News
Conferences + Events
Releases and Archives
Blog
Contact
Contact Us
Scan Locations
Scan Locations
Menu
Products
Imbio Technology
XV LVAS®
CT LVAS™
XV Scanner™
Permetium™
Clinical Research
Clinical Studies
Publications
About
About Us
Our Team
Careers
Veteran Advocacy
Investor Relations
Company Information
Corporate Governance
Results + Reports
Share Price and Tools
Investor Services
Investor Contacts
News
Latest News
Conferences + Events
Releases and Archives
Blog
Contact
Contact Us
Scan Locations
Scan Locations
Category:
Result
Quarterly Activity Report – Clarification
Quarterly Activity Report and Appendix 4C for Q1 FY2023
2022 Annual Report
Appendix 4E – Preliminary Final Report
FY22 Full Year Results
Amended Quarterly Activity Report and Appendix 4C – Q4 FY2022
Quarterly Activity Report and Appendix 4C for Q4 FY2022
Quarterly Activity Report and Appendix 4C for Q34 FY2022
4DMedical Reports 1H FY22 Results
Appendix 4D and Half-Year Financial Report
←
Previous
Next
→
Products
Imbio Technology
XV LVAS®
CT LVAS™
XV Scanner™
Permetium™
Clinical Research
Clinical Studies
Publications
About
About Us
Our Team
Careers
Veteran Advocacy
Investor Relations
Company Information
Corporate Governance
Results + Reports
Share Price and Tools
Investor Services
Investor Contacts
News
Latest News
Conferences + Events
Releases and Archives
Blog
Contact
Contact Us
Scan Locations
Scan Locations
CUSTOMER SUPPORT
Search
Search